Rocket Pharmaceuticals
RCKT
RCKT
51 hedge funds and large institutions have $15M invested in Rocket Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 24 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $20.7M → $15M (-$5.74M)
54% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 24
71% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 21
Holders
51
Holding in Top 10
1
Calls
$1.06M
Puts
$205K
Top Buyers
| 1 | +$218K | |
| 2 | +$215K | |
| 3 | +$212K | |
| 4 |
ECM
Element Capital Management
New York
|
+$175K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
+$126K |
Top Sellers
| 1 | -$1.45M | |
| 2 | -$1.31M | |
| 3 | -$732K | |
| 4 |
FO
FT Options
Chicago,
Illinois
|
-$623K |
| 5 |
State Street
Boston,
Massachusetts
|
-$464K |